Novosti
|
This journal is indexed in Scopus |
---|
Year 2019 Vol. 27 No 6
SCIENTIFIC PUBLICATIONS
GENERAL & SPECIAL SURGE
V.YA. KHRYSHCHANOVICH 1, 2, I.P. KLIMCHUK 1, 3, R. PROCZKA 4, N.А. ROGOVOY 1, 3, S.S. KALININ 1, 3, S. MAZUR 4, Е.V. NELIPOVICH 3
RESULTS OF TRUNCAL ENDOVENOUS MECHANO-CHEMICAL ABLATION IN VARICOSE DISEASE
Belarusian State Medical University 1,
City Clinical Emergency Hospital 2,
4th City Clinical Hospital named after N.E. Savchenko 3, Minsk,
The Republic of Belarus,
Center OF Cardiology and Vascular Surgery «Jozefow» 4, Warsaw,
The Republic of Poland
Objective. To study the long-term (12-months follow-up) results of endovenous mechano-chemical ablation (MOCA) with FlebogrifTM occlusion catheter system for varicose veins (VV) in three vascular centers.
Methods. The study is based on the treatment results of 139 patients with VV. Surgeries were performed using the FlebogrifTM catheter. 123 patients (88.5%) were operated on for incompetence of the great saphenous vein (GSV) on the one side, 6 (4.3%) for bilateral lesions of the GSV, and 8 (5.8%) for the small saphenous vein (SSV) and 2 (1.4%) due to reflux in GSV and SSV. The average diameter of the target GSV and SSV segments was 8.2±1.3 mm and 4.2±1.2 mm, respectively (M±σ). Control examinations of patients were carried out 1, 3, 6 and 12 months after surgery.
Results. One month after the operation, the GSV was completely occluded in 132/136 (97.1%) veins and SSV completely closed in 10/10 (100%) veins. Six months after the endovenous mechano-chemical ablation, the GSV was completely occluded in 99/111 (89.2%) veins and SSV completely closed in 5/6 (83.3%) veins. 12 months after surgery, GSV and SSV occlusion rates were 72/85 (84.7%) and 5/6 (83.3%). There were no significant thrombotic and neurological complications related to the procedure. Skin hyperpigmentation was found in 30/137 GSV treated (21.9%), and along the varicose tributaries in 22 legs (15.2%). Transient superficial phlebitis was reported in 7 of 145 (4.8%) legs. Ecchymosis from the puncture site was reported in 26/145 legs (17.9%).
Conclusions. FlebogrifTM MOCA device is safe and effective method to eliminate the truncal venous reflux for varicose veins, associated with low perioperative pain and minimal complication rate.
- Kanwar A, Hansrani M, Lees T, Stansby G. Trends in varicose vein therapy in England: radical changes in the last decade. Ann R Coll Surg Engl. 2010 May;92(4):341-46. doi: 10.1308/003588410X12518836440649
- Rasmussen LH, Lawaetz M, Bjoern L, Vennits B, Blemings A, Eklof B. Randomized clinical trial comparing endovenous laser ablation, radiofrequency ablation, foam sclerotherapy and surgical stripping for great saphenous varicose veins. Br J Surg. 2011 Aug;98(8):1079-87. doi: 10.1002/bjs.7555
- Marsden G, Perry M, Kelley K, Davies AH; Guideline Development Group. Diagnosis and management of varicose veins in the legs: summary of NICE guidance. BMJ. 2013 Jul 24;347:f4279. doi: 10.1136/bmj.f4279
- Gloviczki P, Comerota AJ, Dalsing MC, Eklof BG, Gillespie DL, Gloviczki ML, Lohr JM, McLafferty RB, Meissner MH, Murad MH, Padberg FT, Pappas PJ, Passman MA, Raffetto JD, Vasquez MA, Wakefield TW. The care of patients with varicose veins and associated chronic venous diseases: clinical practice guidelines of the Society for Vascular Surgery and the American Venous Forum. J Vasc Surg. 2011 May;53(5 Suppl):2S-48S. doi: 10.1016/j.jvs.2011.01.079
- Lane T, Bootun R, Dharmarajah B, Lim CS, Najem M, Renton S, Sritharan K, Davies AH. A multi-centre randomised controlled trial comparing radiofrequency and mechanical occlusion chemically assisted ablation of varicose veins – Final results of the Venefit versus Clarivein for varicose veins trial. Phlebology. 2017 Mar;32(2):89-98. doi: 10.1177/0268355516651026
- Ciostek P, Kowalski M, Wozniak W, Miłek T, Myrcha P, Migda B. Phlebogriffe – a new device for mechanochemical ablation of incompetent saphenous veins: a pilot study. Phlebological Review. 2015;23(3):72-77. doi: 10.5114/pr.2015.57466
- Zubilewicz T, Terlecki P, Terlecki K, Przywara S, Rybak J, Ilzecki M. Application of endovenous mechanochemical ablation (MOCA) with Flebogrif™ to trea varicose veins of the lower extremities: a single center experience over 3 months of observation. Acta Angiologica. 2016; 22(4):137-42. doi: 10.5603/AA.2016.0012
- Tessari L, Cavezzi A, Frullini A. Preliminary experience with a new sclerosing foam in the treatment of varicose veins. Dermatol Surg. 2001 Jan;27(1):58-60. doi: 10.1097/00042728-200101000-00017
- Shepherd AC, Ortega-Ortega M, Gohel MS, Epstein D, Brown LC, Davies AH. Cost-effectiveness of radio frequency ablation versus laser for varicose veins. Int J Technol Assess Health Care. 2015 Jan;31(5):289-96. doi: 10.1017/S0266462315000537
- Witte ME, Zeebregts CJ, deBorst GJ, Reijnen MMPJ, Boersma D. Mechanochemical endovenous ablation of saphenous veins using the ClariVein: A systematic review. Phlebology. 2017 Dec;32(10):649-57. doi: 10.1177/0268355517702068
- Khor SN, Lei J, Kam JW, Kum S, Tan YK, Tang TY. ClariVein™ - One year results of mechano-chemical ablation for varicose veins in a multi-ethnic Asian population from Singapore. Phlebology. 2018 Dec;33(10):687-694. doi: 10.1177/0268355518771225
- Sullivan LP, Quach G, Chapman T. Retrograde mechanico-chemical endovenous ablation of infrageniculate great saphenous vein for persistent venous stasis ulcers. Phlebology. 2014 Dec;29(10):654-57. doi: 10.1177/0268355513501301
- Deijen CL, Schreve MA, BosmaJ, de Nie AJ, Leijdekkers VJ, van den Akker PJ, Vahl A. Clarivein mechano-chemical ablation of the great and small saphenous vein: early treatment outcomes of two hospitals. Phlebology. 2016 Apr;31(3):192-97. doi: 10.1177/0268355515600573
- Tang TY, Kam JW, Gaunt ME. ClariVein® - Early results from a large single-centre series of mechano-chemical endovenous ablation for varicose veins. Phlebology. 2017 Feb;32(1):6-12. doi: 10.1177/0268355516630154
- Sun JJ, Chowdhury MM, Sadat U, Hayes PD, Tang TY. Mechano-chemical ablation for treatment of truncal venous insufficiency: a review of the current literature. J Vasc Interv Radiol. 2017 Oct;28(10):1422-31. doi: 10.1016/j.jvir.2017.07.002
220116, The Republic of Belarus,
Minsk, Dzerzhinski Ave., 83,
Belarusian State Medical University,
2nd Department of Surgical Diseases.
Tel.: +375 17277-11-55,
e-mail: scienceprorektor@bsmu.by,
Vladimir Ya. Khryshchanovich
Khryshchanovich Vladimir Ya., MD, Professor, Vice-Rector for Scientific Work, Professor of the 2nd Department of Surgical Diseases, Belarusian State Medical University, Angiosurgeon, City Clinical Emergency Hospital, Minsk 4th City Clinical Hospital named after N.E. Savchenko, Minsk, Republic of Belarus.
http://orcid.org/0000-0001-5353-205X
Klimchuk Ivan P., PhD, Head of the Department of Vascular Surgery, Minsk 4th City Clinical Hospital named after N.E. Savchenko, Assistant of the General Surgery Department, Belarusian State Medical University, Minsk, Republic of Belarus.
http://orcid.org/0000-0001-9793-0084
Proczka Robert, MD, Head of Centre of Cardiology and Vascular Surgery «Jozefow», Warsaw, Poland.
http://orcid.org/0000-0003-2910-2951
Rogovoy Nickolay A., PhD, Assistant of the General Surgery Department, Belarusian State Medical University, Angiosurgeon of the Department of Vascular Surgery, Minsk 4th City Clinical Hospital named after N.E. Savchenko, Minsk, Republic of Belarus.
http://orcid.org/0000-0002-8386-1791
Kalinin Siarhei S., PhD, Angiosurgeon of the Department of Vascular Surgery, Minsk 4th City Clinical Hospital named after N.E. Savchenko, Assistant of the General Surgery Department, Belarusian State Medical University, Minsk, Republic of Belarus.
http://orcid.org/0000-0003-3180-0409
Mazur Stanislaw, Angiosurgeon, Centre of Cardiology and Vascular Surgery «Jozefow», Warsaw, Poland.
http://orcid.org/0000-0002-0747-9363
Nelipovich Evgenij V., Angiosurgeon of the Department of Vascular Surgery, Minsk 4th City Clinical Hospital named after N.E. Savchenko, Minsk, Republic of Belarus.
http://orcid.org/0000-0002-2921-6601